Format

Send to

Choose Destination
Addiction. 2018 Jan;113(1):113-124. doi: 10.1111/add.13952. Epub 2017 Sep 6.

Adult interest in using a hypothetical modified risk tobacco product: findings from wave 1 of the Population Assessment of Tobacco and Health Study (2013-14).

Author information

1
The Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, DC, USA.
2
Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
3
Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
4
Westat, Rockville, MD, USA.
5
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
6
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
7
Department of Health Behavior, Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, NY, USA.

Abstract

BACKGROUND AND AIMS:

The US Family Smoking Prevention and Tobacco Control Act provides a pathway for manufacturers to market a modified risk tobacco product (MRTP). This study examines socio-demographic and tobacco use correlates of interest in a hypothetical MRTP in a nationally representative sample of US adults.

DESIGN:

Cross sectional wave 1 data from the 2013-14 Population Assessment of Tobacco and Health (PATH) Study.

SETTING:

Household Audio-Computer Assisted Self-Interviews of US adults conducted in 2013-14.

PARTICIPANTS:

A total of 32 320 civilian, non-institutionalized adults in the United States.

MEASUREMENTS:

Interest in using a hypothetical MRTP ('If a tobacco product made a claim that it was less harmful to health than other tobacco products, how likely would you be to use that product?'), socio-demographics, tobacco use history and mental health and substance use problems. All estimates were weighted.

FINDINGS:

Overall, 16.7% [95% confidence interval (CI) = 16.28, 17.18] of US adults reported interest in a hypothetical MRTP. Tobacco use was associated significantly with interest in a hypothetical MRTP, with interest most common among current established smokers (54.4%; 95% CI = 53.31, 55.39) and least common among never tobacco users (3.0%; 95% CI = 2.49, 3.55). Interest in a hypothetical MRTP was associated with experimental e-cigarette use among current experimental, current established and former smokers. Among non-smokers, race, age, education and substance use were associated with interest in using a hypothetical MRTP.

CONCLUSIONS:

Among adults in the United States, interest in using a hypothetical modified risk tobacco product is low overall, and highest among current experimental and established smokers. A small percentage of non-smokers are interested in using a hypothetical hypothetical modified risk tobacco product.

KEYWORDS:

Epidemiology; Food and Drug Administration; Population Assessment of Tobacco and Health; modified risk tobacco products; public health; regulation; study; tobacco

PMID:
28734111
PMCID:
PMC5725239
DOI:
10.1111/add.13952
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center